Novavax
在场
是其中之一......
Novavax 是一家在股票代码 NVAX (US) 下上市的公司。
Novavax 在 2 个国家有直接业务。
高管
查看带有其 35 名主要高管的组织结构图
Novavax 搜索最多的简介
高管在Novavax变化
- Ruxandra Draghia-Akli已作为Executive Vice President and Head of Research & Development加入公司 (新闻发布的2024九月26号).
创建提醒
跟踪 Novavax 的高管变动
生物技术
Novavax 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Novavax 的最新新闻稿
- Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - Nov 15, 2024
- Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 - Nov 4, 2024
- Åsa Manelius Named Managing Director of Novavax AB Site - Nov 4, 2024
- U.S. CDC and ACIP Recommend Additional COVID-19 Vaccine Dose for Older Individuals and Those Who Are Immunocompromised - Oct 24, 2024
- Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial - Oct 16, 2024
- Novavax Update: Where to Find Our COVID-19 Vaccine - Oct 7, 2024
- Press releases & statements | Novavax Investor Relations
- Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU - Oct 9, 2024
- Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development - Sep 25, 2024
- Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S. - Sep 13, 2024
- View more press releases Close
通过电子邮件
